Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) To Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Nov. 01, 2016 (GLOBE NEWSWIRE) --

What: Titan Pharmaceuticals, Inc. (Nasdaq:TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery platform, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Titan President and CEO Sunil Bhonsle, will ring the Closing Bell. 

Where:Nasdaq MarketSite - 4 Times Square - 43 rd & Broadway - Broadcast Studio

When:Wednesday, November 2, 2016 - 3:45 p.m. to 4:00 p.m. ET

Titan Contact:Stephen Kilmer(650) 989-2215 skilmer@titanpharm.com

Nasdaq MarketSite:Emily Pan(646) 441-5120 emily.pan@nasdaq.com

Feed Information:Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

For livestream of ceremonies and events, please visit our YouTube page: http://www.youtube.com/nasdaq/live

For news tweets, please visit our Twitter page: http://twitter.com/nasdaq

For exciting viral content and ceremony photos, please visit our Tumblr page: http://nasdaq.tumblr.com/

Webcast: A live stream of the Nasdaq Closing Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.

About Titan PharmaceuticalsTitan Pharmaceuticals Inc. (NASDAQ:TTNP), based in South San Francisco, CA, is a specialty pharmaceutical company developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product candidate is Probuphine®, a novel and long-acting formulation of buprenorphine for the long-term maintenance treatment of opioid dependence. Probuphine employs Titan's proprietary drug delivery system ProNeura™, which is capable of delivering sustained, consistent levels of medication for three months or longer. Titan has granted commercial rights for the U.S. and Canada for Probuphine to Braeburn Pharmaceuticals. Approved by the FDA in May 2016, Probuphine is the first and only commercialized treatment of opioid dependence to provide continuous, around-the-clock blood levels of buprenorphine for six months following a single procedure. The ProNeura technology has the potential to be used in developing products for treating other chronic conditions such as Parkinson's disease and hypothyroidism, where maintaining consistent, around the clock blood levels of medication may benefit the patient and improve medical outcomes. For more information about Titan, please visit  www.titanpharm.com.

About NasdaqNasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.3 trillion and nearly 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

Primary Logo

If you liked this article you might like

Watch: Meet This New ETF Tracking Blockchain Related Companies Like IBM

Watch: Meet This New ETF Tracking Blockchain Related Companies Like IBM

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Nasdaq, Singapore's SGX Announce Agreement Allowing Collaborative Listings

Nasdaq, Singapore's SGX Announce Agreement Allowing Collaborative Listings

Walt Disney, Tiffany, NASDAQ, Mazor Robotics: 'Mad Money' Lightning Round

Walt Disney, Tiffany, NASDAQ, Mazor Robotics: 'Mad Money' Lightning Round

A Ferocious Rotation: Cramer's 'Mad Money' Recap (Friday 6/9/17)

A Ferocious Rotation: Cramer's 'Mad Money' Recap (Friday 6/9/17)